Associations among sleep problems, learning difficulties and substance use in adolescence

2011 ◽  
Vol 34 (4) ◽  
pp. 717-726 ◽  
Author(s):  
Nuraan Fakier ◽  
Lauren G. Wild
Author(s):  
Maria M. Wong

Individuals with alcohol problems have well-described disturbances of sleep, but the development of these disturbances both before and after the onset of problem drinking is poorly understood. This chapter first discusses sleep physiology and its measurement in humans. It then examines the functions of sleep and its role in development. Next, it reviews recent research on the relationship between sleep and alcohol use and related problems. Whereas sleep problems (e.g., difficulties falling or staying asleep) increase the risk of early onset of alcohol use and related problems, sleep rhythmicity promotes resilience to the development of alcohol use disorder and problem substance use. Based on existing research, this chapter proposes a theoretical model of sleep and alcohol use, highlighting the role of self-regulatory processes as mediators of this relationship.


SLEEP ◽  
2020 ◽  
Vol 43 (Supplement_1) ◽  
pp. A422-A422
Author(s):  
A K Wilkerson ◽  
D J Taylor ◽  
G L Sahlem ◽  
R O Simmons ◽  
A Russell ◽  
...  

Abstract Introduction Previous studies have shown that sleep problems are commonly reported during treatment for substance use disorders (SUDs) and sleep complaints have been linked to subsequent relapse. However, most of these findings were in well-controlled clinical trials and may not generalize to the public. Little is known about the natural progression of sleep complaints during treatment in community clinics, the most common treatment approach for SUDs. The aim of this study is to longitudinally assess prevalence of clinically significant sleep disturbance at baseline and post-treatment in a community-based intensive outpatient (IOP) SUD treatment program using a multi-method approach with well-validated measures of sleep. Methods Adults beginning IOP SUD treatment completed the Pittsburgh Sleep Quality Index (PSQI), Insomnia Severity Index (ISI), Nightmare Disorder index (NDI), and one week of actigraphy and sleep diaries. Measures were repeated following treatment (approximately 5 weeks later). Results Preliminary analyses on 21 adults who have been enrolled thus far revealed 85.6% of participants experienced sleep disturbance (PSQI > 5) at baseline. 28.5% of participants reached cutoff for moderate-to-severe insomnia symptoms (ISI > 15) and 42.9% reported nightmares more than once per week. Sleep parameters taken from actigraphy and sleep diaries revealed mean sleep efficiency was 77.5% (TST M = 6.2 hours; TIB M = 7.9 hours). These variables did not improve from baseline to post-treatment. Further, most measures indicated a worsening of sleep, though this did not reach significance (all ps > .05). Conclusion This preliminary data show a high prevalence of self-reported sleep complaints and objectively measured poor sleep efficiency that do not improve over the course of treatment. Data collection is ongoing and expected to at least double. More robust analyses, including differences between SUD type (e.g., cannabis vs. opioid) and relationship to relapse at post-treatment, will then be completed. Support K12DA031794


2020 ◽  
Vol 9 (9) ◽  
pp. 2862
Author(s):  
Carlos Roncero ◽  
Llanyra García-Ullán ◽  
Alberto Bullón ◽  
Diego Remón-Gallo ◽  
Begoña Vicente-Hernández ◽  
...  

Background: Sleep disorders are often associated with drug use. Nearly 70% of patients admitted for detoxification report sleep problems. Dual disorder (DD) is the comorbidity between mental disorders in general and disorders related to psychoactive substance use. The association between substance use and sleep disorders (SD) appears to be bidirectional. Our objective is to analyze the association between sleep disturbance history and drug use pattern (alcohol, cannabis, opioids, and cocaine). Methods: Analysis of data in the first interview at the Addictions Unit of the Department of Psychiatry at the University of Salamanca Health Care Complex between October 2017 and January 2020. The sample consists of 398 patients. We studied the association between different variables: origin of patients (Inpatient Dual Diagnosis Detoxification Unit (IDDDU) vs. Outpatient Drug Clinic (ODC), presence of affective disorder, psychotic disorder, type of drug used, and treatment. Results: Of patients with DD, 62% had more delayed sleep induction, sleep fragmentation, early awakening, and nightmares. Outpatients had more difficulty falling asleep because, in many cases, they had not previously sought any medical assistance. On the other hand, 67% of the patients with insomnia presented depression. Conclusions: There is evidence of a harmful association between DD and SD.


2011 ◽  
Vol 53 (8) ◽  
pp. 928-933 ◽  
Author(s):  
Mary G. Carey ◽  
Salah S. Al-Zaiti ◽  
Grace E Dean ◽  
Loralee Sessanna ◽  
Deborah S. Finnell

2009 ◽  
Vol 10 (7) ◽  
pp. 787-796 ◽  
Author(s):  
Maria M. Wong ◽  
Kirk J. Brower ◽  
Robert A. Zucker

2021 ◽  
pp. 3-18
Author(s):  
Mark Selikowitz

This chapter discusses what ADHD is, including an overview of the features of ADHD, features of the inattentive type of ADHD (poor concentration, task impersistence, disorganization, forgetfulness), features of the combined type of ADHD (impulsivity, overactivity, noisiness), and features that may be present in either type of ADHD (performance inconsistency, low self-esteem, poor working memory, poor incentival motivation, social clumsiness, learning difficulties, inflexibility, insatiability, defiant behaviour, sleep problems), as well as associated conditions, prevalence, and a historical background.


Sign in / Sign up

Export Citation Format

Share Document